<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531192</url>
  </required_header>
  <id_info>
    <org_study_id>ZTB630301</org_study_id>
    <nct_id>NCT01531192</nct_id>
  </id_info>
  <brief_title>Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants</brief_title>
  <official_title>Zekai Tahir Burak Maternity Teaching Hospital, Ankara/Turkey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal
      system and stimulate the immune system. Lactobacillus reuteri was shown to reduce candida
      colonization. The objective of this study is to evaluate the efficacy of prophylactic
      Lactobacillus reuteri in reducing the candida colonization and infection in very low birth
      weight infants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of prophylactic Lactobacillus reuteri and nystatin on candida colonization and infection in very low birth weight infants</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Rectal and skin swabs for Candida colonization will be taken weekly. Blood culture for Candida infection will be taken weekly.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on feeding intolerance</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Feeding intolerance (gastric residuals in the amount that was more than half of the previous feeding, abdominal distention or heme-positive stools)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on sepsis</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Patients with culture positivity will accept as proven sepsis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on length of hospital stay</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Specified length of hospital stay as days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Lactobacillus reuteri on necrotizing enterocolitis in VLBW infants</measure>
    <time_frame>up to 6 months</time_frame>
    <description>NEC diagnosis will make modified Bell's criteria. Grade 1A will not include in NEC group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Very Low Birth Weight Infants</condition>
  <arm_group>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus reuteri 100 million CFU/day for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nystatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50000 unit/3 times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri</intervention_name>
    <description>Lactobacillus reuteri 100 million CFU/day for 3 months</description>
    <arm_group_label>Lactobacillus reuteri</arm_group_label>
    <other_name>BioGaia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nystatin</intervention_name>
    <description>50000 unit/3 times a day, both for orally and by orogastric route</description>
    <arm_group_label>Nystatin</arm_group_label>
    <other_name>Mikostatin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Very low birth weight infants &lt; 1500 gr

          -  Gestational age &lt; 32 weeks

        Exclusion Criteria:

          -  Genetic anomalies

          -  Short bowel syndrome

          -  Not willing to participate

          -  Allergy to Lactobacillus reuteri components
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehmet Yekta Oncel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://druginfo.nlm.nih.gov/drugportal/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=drugportal&amp;actionHandle=default&amp;nextPage=jsp/drugportal/ResultScreen.jsp&amp;TXTSUPERLISTID=L040030000&amp;QV1=LACTOBACILLUS+REUTERI</url>
    <description>Lactobacillus reuteri</description>
  </link>
  <link>
    <url>http://druginfo.nlm.nih.gov/drugportal/ProxyServlet?mergeData=true&amp;objectHandle=DBMaint&amp;APPLICATION_NAME=drugportal&amp;actionHandle=default&amp;nextPage=jsp/drugportal/ResultScreen.jsp&amp;TXTSUPERLISTID=0001400619&amp;QV1=NYSTATIN</url>
    <description>Nystatin</description>
  </link>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2012</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>July 13, 2013</last_update_submitted>
  <last_update_submitted_qc>July 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Yekta</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Lactobacillus reuteri</keyword>
  <keyword>Nystatin</keyword>
  <keyword>Very Low Birth Weight Infants</keyword>
  <keyword>Candida Colonization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nystatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

